Investors
Investor Information
Revolo Biotherapeutics is a privately held, venture-funded biotechnology firm engaged in the development of unique and revolutionary therapies. Looking to learn more? Don’t hesitate to contact us.
![](https://revolobio.com/wp-content/uploads/investors-hero.png)
Events
Upcoming Events
There are no upcoming events at this time.
Past Events
26
Feb
February 26th & 27th 2024 – BIO CEO & Investor Conference
1:1 meetings – New York
29
Aug
Presentation – ‘1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease – Virtual
30
May
Presentation – Targeting Tissue Resident Tregs in Autoimmune Disease Revolutionary Approach to Resetting the Immune System for Long-Term Autoimmune Disease Remission – Boston
Investors
![](https://revolobio.com/wp-content/uploads/investors_morningside_2x-3.png)
![24 Haymarket (UK)](https://revolobio.com/wp-content/uploads/investors_24haymarket_2x.png)
![Metellus AG (Switzerland)](https://revolobio.com/wp-content/uploads/investors_metellusag_2x.png)